Letters Drug pricing

Author's reply

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39339.460127.3A (Published 20 September 2007) Cite this as: BMJ 2007;335:578
  1. Ike Iheanacho, editor, Drug and Therapeutics Bulletin
  1. BMA House, London WC1H 9JR
  1. ike.iheanacho{at}bmjgroup.com

    Burnand gives a predictable, if disappointing, response from an industry that has done very well out of the unequivocally flawed Pharmaceutical Price Regulation Scheme. In seeking to …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe